Cost Analysis Shows Vadadustat Lowers Hospitalization Costs Compared to Darbepoetin Alfa in Dialysis-Dependent CKD Patients
2026-06-03
PubComNonGov2026-06-03
Carter Struck
WASHINGTON, June 3 -- Akebia Therapeutics Inc., Cambridge, Massachusetts, submitted a public comment letter to the U.S. Department of Health & Human Services presenting a cost comparison analysis of h . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and individuals; as well as 'gathered' public policy information, including news releases, reports, speeches. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, June 3 -- Akebia Therapeutics Inc., Cambridge, Massachusetts, submitted a public comment letter to the U.S. Department of Health & Human Services presenting a cost comparison analysis of h . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and individuals; as well as 'gathered' public policy information, including news releases, reports, speeches. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
Copyright © Targeted News Service, 2026